Tissue distribution of 2-(2-nitro-4-trifluoromethylbenzoyl)cyclohexane-1,3-dione (NTBC): Effect on enzymes involved in tyrosine catabolism and relevance to ocular toxicity in the rat

被引:34
|
作者
Lock, EA [1 ]
Gaskin, P [1 ]
Ellis, MK [1 ]
Provan, WM [1 ]
Robinson, M [1 ]
Smith, LL [1 ]
Prisbylla, MP [1 ]
Mutter, LC [1 ]
机构
[1] ZENECA AGROCHEM PROD,WESTERN RES CTR,RICHMOND,CA 94804
关键词
D O I
10.1006/taap.1996.0310
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Administration of a single oral dose of 2-(2-nitro-4-trifluoromethylbenzoyl)cyclohexane-1,3-dione (NTBC) to rats produced a marked tyrosinemia in the plasma and aqueous humor. The tyrosinemia was both time- and dose-dependent with the duration being more marked at the higher doses. The dose-response curve was very steep with a single dose of 1.5 mu mol NTBC/kg (0.5 mg/kg) and above producing maximal concentrations of tyrosine in plasma of about 2500 nmol/ml and in aqueous humor of about 3500-4000 nmol/ml at 24 hr after dosing. Analysis of the key hepatic enzymes involved in tyrosine catabolism showed that 4-hydroxyphenylpyruvate dioxygenase (HPPD) was markedly inhibited soon after dosing at either 0.3 or 30 mu mol/kg (0.1 or 10 mg/kg) NTBC and that the activity recovered very slowly. In response to the tyrosinemia, the activity of tyrosine aminotransferase (TAT) in the liver was induced about twofold, while the activity of homogentisic acid oxidase (HGO) was not affected. Daily oral administration of NTBC for 6 weeks induced lesions to the cornea of the eye, with a dose of 0.3 mu mol/kg/day producing about a 38% incidence and a higher dose of 30 mu mol/kg/day a 75% incidence. Administration of a single oral dose of [C-14]NTBC at either 0.3 or 30 mu mol/kg led to selective retention of radiolabel in the liver and to a lesser extent in the kidneys and the Harderian gland. Concentrations of radioactivity in the liver and kidneys remained constant over 4 days and after the lower NTBC dose were about 2 nmol/g wet wt and 0.9 nmol/g wet wt, respectively. Subcellular fractionation of the liver showed that the majority of the radiolabel, >90%, was associated reversibly with the cytosol fraction. No retention of radiolabel was detected in the cornea, the site of toxicity. Our studies indicate that NTBC binds to protein in rat liver cytosol, inhibits the hepatic cytosolic enzyme HPPD, and causes a marked and sustained tyrosinemia. We suggest that this marked and sustained ocular tyrosinemia produced by NTBC in the rat is responsible for the corneal lesions since similar corneal lesions are produced by feeding rats a high tyrosine diet. (C) 1996 Academic Press, Inc.
引用
收藏
页码:439 / 447
页数:9
相关论文
共 20 条
  • [1] Tissue distribution of 2-(2-nitro-4-trifluoromethylbenzoyl)-cyclohexane-1,3-dione (NTBC) and its effect on enzymes involved in tyrosine catabolism in the mouse
    Lock, EA
    Gaskin, P
    Ellis, MK
    Provan, WM
    Robinson, M
    Smith, LL
    [J]. TOXICOLOGY, 2000, 144 (1-3) : 179 - 187
  • [2] INHIBITION OF 4-HYDROXYPHENYLPYRUVATE DIOXYGENASE BY 2-(2-NITRO-4-TRIFLUOROMETHYLBENZOYL)-CYCLOHEXANE-1,3-DIONE AND 2-(2-CHLORO-4-METHANESULFONYLBENZOYL)-CYCLOHEXANE-1,3-DIONE
    ELLIS, MK
    WHITFIELD, AC
    GOWANS, LA
    AUTON, TR
    PROVAN, WM
    LOCK, EA
    SMITH, LL
    [J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 1995, 133 (01) : 12 - 19
  • [3] Tyrosinemia produced by 2-(2-nitro-4-trifluoromethylbenzoyl)-cyclohexane-1,3-dione (NTBC) in experimental animals and its relationship to corneal injury
    Lock, Edward A.
    Gaskin, Peter
    Ellis, Martin
    Provan, William M.
    Smith, Lewis L.
    [J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 2006, 215 (01) : 9 - 16
  • [5] The effect of a low-protein diet and dietary supplementation of threonine on tyrosine and 2-(2-nitro-4-trifluoromethylbenzoyl)cyclohexane-1,3-dione-induced corneal lesions, the extent of tyrosinemia, and the activity of enzymes involved in tyrosine catabolism in the rat
    Lock, EA
    Gaskin, P
    Ellis, MK
    Robinson, M
    Provan, WM
    Smith, LL
    [J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 1998, 150 (01) : 125 - 132
  • [6] Tyrosinaemia type I and NTBC (2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione)
    Holme, E
    Lindstedt, S
    [J]. JOURNAL OF INHERITED METABOLIC DISEASE, 1998, 21 (05) : 507 - 517
  • [7] Effects of sulcotrione [2-(2-chloro-4-mesylbenzoyl)-cyclohexane-1,3-dione] on enzymes involved in tyrosine catabolism and the extent of the resulting tyrosinemia and its relationship with corneal lesions in rats
    Wu, Nanxiang
    Jin, Yong
    Jin, Feng
    Tan, Yufeng
    Tao, He
    Zheng, Mingyou
    Chen, Riping
    Liu, Kecheng
    Gao, Ming
    [J]. PESTICIDE BIOCHEMISTRY AND PHYSIOLOGY, 2011, 99 (02) : 162 - 169
  • [8] Clinical follow up of Chilean patients with tyrosinemia type 1 treated with 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-ciclohexanedione (NTBC)
    Raimann, Erna
    Cornejo, Veronica
    Arias, Carolina
    Francisco Cabello, Juan
    Castro, Gabriela
    Fernandez, Eloina
    de la Parra, Alicia
    [J]. REVISTA MEDICA DE CHILE, 2012, 140 (02) : 169 - 175
  • [9] The effectiveness of 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione (NTBC) as a therapeutic agent for tyrosinemia-I: The US experience
    Scott, CR
    Sniderman, LC
    Smith, CO
    Feldman, K
    [J]. PEDIATRIC RESEARCH, 2000, 47 (04) : 168A - 168A
  • [10] NEW REACTION OF CYCLIC AZOMETHINES ANNELATION BY 2-(4-THIAZOLYL)CYCLOHEXANE-1,3-DIONE
    GULYAKEVICH, OV
    MIKHALCHUK, AL
    [J]. ZHURNAL ORGANICHESKOI KHIMII, 1995, 31 (02): : 302 - 303